Breast cancer research at Lund University is world-renown for its high-quality biobanks and long-standing expertise in clinical trials, high-throughput methods, advanced machine learning, and functional model systems.  The main questions that breast cancer research at Lund University are trying to answer include why a 5-year survival after breast cancer is not necessarily a cure, what are the underlying genetic, genomic, and epigenetic defects which drive breast cancer progression and can we intercept these intracellular and extracellular signaling pathways, and how can we – with greater precision and personalization – prevent, diagnose, predict, monitor, and treat the patients who are at highest and lowest risk for relapse and death?

The purpose of the LUCC-Breast network is to:

• provide a platform and venue for our breast cancer researchers to connect with each other and freely exchange ideas, share expertise, and increase collaboration
• in order to accelerate discovery, innovation, and knowledge growth with the ultimate goal of improving the outcomes and quality of life of breast cancer patients.

The LUCC-Breast network organizes regular meetings, symposia, invited speakers, and other scientific and social activities (see LUCC calendar).  To learn more, contact the co-leaders Sara or Lao.